SCHEMBL19644583

SCHEMBL19644583

C[C@]1(CO)O[C@@H](c2csc3c(N)ncnc23)[C@H](O)[C@@H]1O

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.39
▸ IRAK4 Q9NWZ3 1/20 0.32
▸ ADORA2A P29274 3/20 0.31
▸ ADORA3 P0DMS8 2/20 0.31
▸ PNP P00491 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17453478 0.81 HIF1A (0.37) HIF1A
SCHEMBL19962801 0.80 HIF1A (0.38) HIF1A
SCHEMBL21137371 0.80 HIF1A (0.34) HIF1AIRAK4
SCHEMBL21136494 0.79 HIF1A (0.33) HIF1AIRAK4
SCHEMBL21137368 0.79 HIF1A (0.33) HIF1AIRAK4
SCHEMBL21137374 0.79 HIF1A (0.33) HIF1AIRAK4
SCHEMBL21137072 0.79 HIF1A (0.33) HIF1AIRAK4
SCHEMBL21137365 0.78 HIF1A (0.33) HIF1AIRAK4
SCHEMBL19644607 0.76 HIF1A (0.37) HIF1A
SCHEMBL19644597 0.76 HIF1A (0.37) HIF1APNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4023650-A1 4'-SUBSTITUTED-FURO[3,2-D]PYRIMIDINE AND -PYRROLO[3,2- D]PYRIMIDINE DERIVATIVES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2022-07-06 — — EP disclosed
EP-3174870-B1 THIENO [3,2-D]PYRIMIDINES, FURO [3,2,D]PYRIMIDINES AND PYRROLO [3,2-D]PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES INC (US) 2020-04-15 — — EP disclosed
US-9828388-B2 Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-D]pyrimidines useful for treating respiratory syncitial virus infections GILEAD SCIENCES, INC. (US) 2017-11-28 — — US disclosed
Send feedback